Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
2.755
+0.005 (0.18%)
Dec 12, 2025, 12:48 PM EST - Market open

Dermata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
332514-
Upgrade
Market Cap Growth
21.86%27.62%-56.38%-65.85%--
Upgrade
Enterprise Value
-2-3-4-32-
Upgrade
Last Close Price
2.7513.5091.50981.604176.00-
Upgrade
PB Ratio
0.591.770.340.821.43-
Upgrade
P/TBV Ratio
0.711.770.340.821.43-
Upgrade
Debt / Equity Ratio
------1.12
Upgrade
Quick Ratio
4.201.604.586.787.120.14
Upgrade
Current Ratio
4.561.794.917.537.660.16
Upgrade
Return on Equity (ROE)
-203.36%-310.44%-125.96%-119.18%-228.09%-
Upgrade
Return on Assets (ROA)
-96.45%-135.86%-67.36%-65.13%-80.31%-148.47%
Upgrade
Return on Capital (ROIC)
-130.35%-197.59%-81.22%-74.98%-93.76%-275.18%
Upgrade
Return on Capital Employed (ROCE)
-229.10%-801.60%-126.50%-160.70%-77.70%99.80%
Upgrade
Earnings Yield
-313.44%-446.00%-361.07%-194.19%-54.53%-
Upgrade
Buyback Yield / Dilution
-871.92%-684.78%----
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q